Portal hypotensive effects of tetrandrine and verapamil in portal hypertensive rats

Journal of Pharmacy and Pharmacology

Volumn 49, Issue 1, 1997, Pages 85-88

  Liu, Tsun Bin ^a   Lin, Han Chieh ^b   Huang, Yi Tsau ^a   Sun, Chang Ming ^c   Hong, Chuang Ye ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

TETRANDRINE; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOSE RESPONSE; HEART RATE; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; RAT;

EID: 0031028079     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06757.x     Document Type: Article

References (15)

1. Chojkier, M., Groszmann, R. J. (1981) Measurement of portal systemic shunting in the rat by using γ-labeled microspheres. Am. J. Physiol. 240: G371-G375
2. D'Amico, G., Pagliaro, L., Bosch, J. (1995) The treatment of portal hypertension: a meta-analytic review. Hepatology 22: 332-354
3. Huang, Y.-T., Wang, G.-F., Chen, C.-F., Chen, C.-C., Hong, C.-Y., Yang, M. C.-M. (1995) Fructus Aurantii reduced portal pressure in portal hypertensive rats. Life Sci. 57: 2011-2020
4. Imperiale, T. F., Teran, J. C., McCullouch, A. J. (1995) A meta-analysis of somatostatin versus vasopressin in the management of acute esophageal variceal hemorrhage. Gastroenterology 109: 1289-1294
5. Kong, C.-W., Lay, C.-S., Tsai, Y.-T., Yeh, C.-L., Lai, K.-H., Lee, S.-D., Lo, K.-J., Chiang, B. N. (1986) The hemodynamic effect of verapamil on portal hypertension in patients with postnecrotic cirrhosis. Hepatology 6: 423-426
6. Lay, C.-S., Tsai, Y.-T., Kong, C.-W., Lee, F-Y., Lee, S.-D., Chen, K.-Y., Chiang, B. N., Lo, K.-J. (1988) Effects of verapamil on estimated hepatic blood flow in patients with HBsAg-positive cirrhosis. Hepatogastroenerology 35: 121-124
7. Lay, C.-S., Tsai, Y.-T., Yang, C.-M., Chen, H.-I., Simchon, S., Chien, S., Lo, K.-J. (1990) Effect of verapamil on splanchnic haemodynamics in a portal hypertensive rat model. J. Gastroenterol. Hepatol. 5: 141-148
8. Lebrec, D. (1994) Pharmacological treatment of portal hypertension: hemodynamic effects and prevention of bleeding. Pharmacol. Ther. 61: 65-107
9. Liu, Q.-Y., Li, B., Gang, J.-M., Karpinski, E., Pang, P. K. T. (1995) Tetrandrine, an antagonist: effects and mechanisms of action in vascular smooth muscle cells. J. Pharmacol. Exp. Ther. 273: 32-39
10. Opie, L. H. (1996) Calcium channel antagonists in the treatment of coronary artery disease: fundamental pharmacological properties relevant to clinical use. Prog. Cardiovasc. Dis. 38: 273-290
11. Qian, J. Q., Thoolen, M. J. M. C., van Meel, J. C. A., Timmermans, P. B. M. W. M., van Zwieten, P. A. (1983) Hypotensive activity of tetrandrine in rats: investigation into its mode of action. Pharmacology 26: 187-197
12. Reichen, J. (1990) Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension. Hepatology 11: 1066-1078
13. Reichen, J., Le, M. (1986) Verapamil favorably influences hepatic microvascular exchange and function in rats with cirrhosis of liver. J. Clin. Invest. 78: 448-455
14. Reichen, J., Hirlinger, A., Ha, H. R., Sagesser, S. (1986) Chronic verapamil administration lowers portal pressure and improves hepatic function in rats with liver cirrhosis. J. Hepatol. 3: 49-58
15. + channels. Life Sci. 56: 295-306